>Merck's drug, molnupiravir was shown to reduce hospitalizations and deaths by around 30% in a clinical trial of high-risk individuals https://pubchem.ncbi.nlm.nih.gov/compound/145996610 GHS Hazard Statements H372 (97.22%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]